Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Phyllis Gardner currently holds 117,024 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Phyllis Gardner has been a net seller of RVNC stock. They have purchased $0 and sold $168.0K worth of shares.
Phyllis Gardner's most recent insider trade was on Jun 13, 2023, when they sold 35,354 shares at $4.95 per share.
Phyllis Gardner serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 18 insider transactions totaling $168.0K over their tenure at the company.
Phyllis Gardner holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Phyllis Gardner has shown a selling trading pattern, with $0 in total purchases and $168.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Phyllis Gardner was on Nov 27, 2018, when they sold $427.5K worth of CORI shares. This transaction involved 34,203 shares at $12.50 per share.
Phyllis Gardner currently owns 117,024 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Phyllis Gardner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Phyllis Gardner has 18 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for Phyllis Gardner and 40,000+ other insiders.